Vanguard Fiduciary Trust
CTSO icon

Vanguard Fiduciary Trust’s Cytosorbents Corp CTSO Stock Holding History

Vanguard Fiduciary Trust’s Portfolio CTSO Stock Details CTSO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$118K Buy
316,167
+2,311
+0.7% +$1.22K ﹤0.01% 3710
2026
Q1 		$178K Buy
+313,856
New +$214K ﹤0.01% 3552

Other funds holding CTSO

AC
Avenir Corporation Alexandria, Virginia $821M AUM 4.23% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CM
CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return
SC
Skylands Capital Milwaukee, Wisconsin $814M AUM 32.37% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return
Pathstone Holdings
Pathstone Holdings Englewood, New Jersey $34.3B AUM 27.35% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM

Vanguard Fiduciary Trust's CTSO Position: Q2 2026 in Review

Vanguard Fiduciary Trust increased its Cytosorbents Corp (CTSO) stake by 0.74% in Q2 2026, buying an estimated $1.22K and bringing the position to 316,167 shares worth $118K. The position accounts for ﹤0.01% of the portfolio, ranked #3710.

Vanguard Fiduciary Trust first reported a position in CTSO in Q1 2026 and has held it in 2 quarters since. The position peaked at $178K in Q1 2026. 50 funds tracked by Wall St. Rank hold CTSO as of Q2 2026.

  • Vanguard Fiduciary Trust held 316,167 shares of Cytosorbents Corp worth $118K as of Q2 2026.
  • Vanguard Fiduciary Trust bought 2,311 Cytosorbents Corp shares in Q2 2026, an estimated $1.22K.
  • Cytosorbents Corp made up ﹤0.01% of Vanguard Fiduciary Trust's portfolio in Q2 2026, its #3710 holding.
  • Vanguard Fiduciary Trust first reported a position in Cytosorbents Corp in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Fiduciary Trust's Cytosorbents Corp position peaked at $178K in Q1 2026.
  • 50 funds tracked by Wall St. Rank held Cytosorbents Corp as of Q2 2026.

Based on Vanguard Fiduciary Trust's 13F filing for Q2 2026, filed 13 Aug 2026.